Insmed Inc (STU:IM8N)
€ 68 2 (3.03%) Market Cap: 12.18 Bil Enterprise Value: 11.75 Bil PE Ratio: 0 PB Ratio: 26.52 GF Score: 63/100

Insmed Inc at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 09:15PM GMT
Release Date Price: €16.38 (+3.47%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

So great. So thanks for sticking around for the last session today. Very pleased to have Insmed with us; and Will Lewis, the CEO.

Just quickly before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures, or you can pick up a very personal copy at the registration desk.

So Will, I thought what we could do is -- first, I don't know if you want to make any opening comments. If you do, feel free.

William H. Lewis
Insmed Incorporated - President, CEO & Chairman

No. I'll take your lead and move on from there...

Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Okay. Perfect. Good. So look, what I thought we could do is -- there are probably 3 or 4 metrics and some controversies around those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot